MedPath

Investigation of genome-wide SNP analysis and its significance in KYUCOG-1401 (randomized controlled study of GnRH antagonist monotherapy and CAB with GnRH agonist plus bicartamide for patients with metastatic prostate cancer).

Not Applicable
Conditions
Metastatic prostate cancer
Registration Number
JPRN-UMIN000022852
Lead Sponsor
Department of Urology, Kyushu University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Male
Target Recruitment
229
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients in the ethnic group or the race except the Japanese (2) Any other patients who are regarded as unsuitable for this study by the investigators.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Genome-wide SNP analysis using Japonica array.
Secondary Outcome Measures
NameTimeMethod
Correlation between SNP information and clinical information (subject characteristics, clinical laboratory test, imaging test and endpoints) in KYUCOG-1401.
© Copyright 2025. All Rights Reserved by MedPath